Lifecourse socioeconomic status and type 2 diabetes: The role of chronic inflammation in the English Longitudinal Study of Ageing

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Stringhini, Silvia ^a   Zaninotto, Paola ^b   Kumari, Meena ^c   Kivimäki, Mika ^b   Batty, G David ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; ENGLAND; FEMALE; HUMAN; INCIDENCE; INFLAMMATION; LIFESTYLE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SOCIAL CLASS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK ASSESSMENT; SOCIAL CLASS;

EID: 84964257993     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24780     Document Type: Article

References (30)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128, doi: 10.1016/S0140-6736(12)61728-0 (2012).
2. Murray, C. J. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223, doi: 10.1016/S0140-6736(12)61689-4 (2012).
3. Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T. & Sidorchuk, A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 40, 804-818, doi: 10.1093/ije/dyr029 (2011).
4. Stringhini, S. et al. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 345, e5452, doi: 10.1136/bmj.e5452 (2012).
5. Stringhini, S. et al. Association of Lifecourse Socioeconomic Status with Chronic Inflammation and Type 2 Diabetes Risk: The Whitehall II Prospective Cohort Study. PLoS Med 10, e1001479, doi: 10.1371/journal.pmed.1001479 (2013).
6. Krishnan, S., Cozier, Y. C., Rosenberg, L. & Palmer, J. R. Socioeconomic status and incidence of type 2 diabetes: results from the Black Women's Health Study. Am J Epidemiol 171, 564-570, doi: 10.1093/aje/kwp443 (2010).
7. Smith, B. T. et al. Life-course socioeconomic position and type 2 diabetes mellitus: The Framingham Offspring Study. Am J Epidemiol 173, 438-447, doi: 10.1093/aje/kwq379 (2011).
8. Demakakos, P., Marmot, M. & Steptoe, A. Socioeconomic position and the incidence of type 2 diabetes: the ELSA study. Eur J Epidemiol 27, 367-378, doi: 10.1007/s10654-012-9688-4 (2012).
9. Hsu, C. C. et al. Poverty increases type 2 diabetes incidence and inequality of care despite universal health coverage. Diabetes Care 35, 2286-2292, doi: 10.2337/dc11-2052 (2012).
10. Miller, G. E. et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci USA 106, 14716-14721, doi: 10.1073/pnas.0902971106 (2009).
11. Hemingway, H. et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 92, 984-987 (2003).
12. Jousilahti, P., Salomaa, V., Rasi, V., Vahtera, E. & Palosuo, T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 57, 730-733 (2003).
13. Alley, D. E. et al. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 20, 498-504, doi: 10.1016/j.bbi.2005.10.003 (2006).
14. Loucks, E. B. et al. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 163, 622-628, doi: 10.1093/aje/kwj076 (2006).
15. Fraga, S. et al. Association of socioeconomic status with inflammatory markers: a two cohort comparison. Prev Med 71, 12-19, doi: 10.1016/j.ypmed.2014.11.031 (2015).
16. Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E. & Ridker, P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334 (2001).
17. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867, doi: 10.1038/nature05485 (2006).
18. Donath, M. Y. et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54 Suppl 2, S108-113 (2005).
19. Mohamed-Ali, V. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-4200 (1997).
20. Steptoe, A., Breeze, E., Banks, J. & Nazroo, J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol 42, 1640-1648, doi: 10.1093/ije/dys168 (2013).
21. World Health Organisation. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation (2011).
22. Tabak, A. G. et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373, 2215-2221, doi: 10.1016/s0140-6736(09)60619-x (2009).
23. World Health Organisation. The challenge of obesity in the WHO European Region and the strategies for response. 1 edn, (WHO, 2007).
24. Stringhini, S. et al. Lifecourse socioeconomic status and DNA methylation of genes regulating inflammation. Int J Epidemiol in press (2015).
25. Needham, B. L. et al. Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: The multi-ethnic study of atherosclerosis. Epigenetics 10, 958-969, doi: 10.1080/15592294.2015.1085139 (2015).
26. Borghol, N. et al. Associations with early-life socio-economic position in adult DNA methylation. Int J Epidemiol 41, 62-74, doi: 10.1093/ije/dyr147 (2012).
27. Abramson, J. L. & Vaccarino, V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 162, 1286-1292 (2002).
28. Franks, P. W. Obesity, inflammatory markers and cardiovascular disease: distinguishing causality from confounding. J Hum Hypertens 20, 837-840, doi: 10.1038/sj.jhh.1002059 (2006).
29. O'Connor, M. F. et al. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 23, 887-897, doi: 10.1016/j.bbi.2009.04.005 (2009).
30. Scott, K. A., Melhorn, S. J. & Sakai, R. R. Effects of Chronic Social Stress on Obesity. Current obesity reports 1, 16-25, doi: 10.1007/ s13679-011-0006-3 (2012).